1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Type 1 Diabetes Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Rapid Acting Insulin Analogs 1.2.3 Long Acting Insulin Analogs 1.2.4 Premix Insulin Analogs 1.3 Market by Application 1.3.1 Global Type 1 Diabetes Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Diagnostic clinics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Type 1 Diabetes Market Perspective (2016-2027) 2.2 Type 1 Diabetes Growth Trends by Regions 2.2.1 Type 1 Diabetes Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Type 1 Diabetes Historic Market Share by Regions (2016-2021) 2.2.3 Type 1 Diabetes Forecasted Market Size by Regions (2022-2027) 2.3 Type 1 Diabetes Industry Dynamic 2.3.1 Type 1 Diabetes Market Trends 2.3.2 Type 1 Diabetes Market Drivers 2.3.3 Type 1 Diabetes Market Challenges 2.3.4 Type 1 Diabetes Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Type 1 Diabetes Players by Revenue 3.1.1 Global Top Type 1 Diabetes Players by Revenue (2016-2021) 3.1.2 Global Type 1 Diabetes Revenue Market Share by Players (2016-2021) 3.2 Global Type 1 Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Type 1 Diabetes Revenue 3.4 Global Type 1 Diabetes Market Concentration Ratio 3.4.1 Global Type 1 Diabetes Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Type 1 Diabetes Revenue in 2020 3.5 Type 1 Diabetes Key Players Head office and Area Served 3.6 Key Players Type 1 Diabetes Product Solution and Service 3.7 Date of Enter into Type 1 Diabetes Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Type 1 Diabetes Breakdown Data by Type 4.1 Global Type 1 Diabetes Historic Market Size by Type (2016-2021) 4.2 Global Type 1 Diabetes Forecasted Market Size by Type (2022-2027) 5 Type 1 Diabetes Breakdown Data by Application 5.1 Global Type 1 Diabetes Historic Market Size by Application (2016-2021) 5.2 Global Type 1 Diabetes Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Type 1 Diabetes Market Size (2016-2027) 6.2 North America Type 1 Diabetes Market Size by Type 6.2.1 North America Type 1 Diabetes Market Size by Type (2016-2021) 6.2.2 North America Type 1 Diabetes Market Size by Type (2022-2027) 6.2.3 North America Type 1 Diabetes Market Size by Type (2016-2027) 6.3 North America Type 1 Diabetes Market Size by Application 6.3.1 North America Type 1 Diabetes Market Size by Application (2016-2021) 6.3.2 North America Type 1 Diabetes Market Size by Application (2022-2027) 6.3.3 North America Type 1 Diabetes Market Size by Application (2016-2027) 6.4 North America Type 1 Diabetes Market Size by Country 6.4.1 North America Type 1 Diabetes Market Size by Country (2016-2021) 6.4.2 North America Type 1 Diabetes Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Type 1 Diabetes Market Size (2016-2027) 7.2 Europe Type 1 Diabetes Market Size by Type 7.2.1 Europe Type 1 Diabetes Market Size by Type (2016-2021) 7.2.2 Europe Type 1 Diabetes Market Size by Type (2022-2027) 7.2.3 Europe Type 1 Diabetes Market Size by Type (2016-2027) 7.3 Europe Type 1 Diabetes Market Size by Application 7.3.1 Europe Type 1 Diabetes Market Size by Application (2016-2021) 7.3.2 Europe Type 1 Diabetes Market Size by Application (2022-2027) 7.3.3 Europe Type 1 Diabetes Market Size by Application (2016-2027) 7.4 Europe Type 1 Diabetes Market Size by Country 7.4.1 Europe Type 1 Diabetes Market Size by Country (2016-2021) 7.4.2 Europe Type 1 Diabetes Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Type 1 Diabetes Market Size (2016-2027) 8.2 Asia-Pacific Type 1 Diabetes Market Size by Type 8.2.1 Asia-Pacific Type 1 Diabetes Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Type 1 Diabetes Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Type 1 Diabetes Market Size by Type (2016-2027) 8.3 Asia-Pacific Type 1 Diabetes Market Size by Application 8.3.1 Asia-Pacific Type 1 Diabetes Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Type 1 Diabetes Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Type 1 Diabetes Market Size by Application (2016-2027) 8.4 Asia-Pacific Type 1 Diabetes Market Size by Region 8.4.1 Asia-Pacific Type 1 Diabetes Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Type 1 Diabetes Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Type 1 Diabetes Market Size (2016-2027) 9.2 Latin America Type 1 Diabetes Market Size by Type 9.2.1 Latin America Type 1 Diabetes Market Size by Type (2016-2021) 9.2.2 Latin America Type 1 Diabetes Market Size by Type (2022-2027) 9.2.3 Latin America Type 1 Diabetes Market Size by Type (2016-2027) 9.3 Latin America Type 1 Diabetes Market Size by Application 9.3.1 Latin America Type 1 Diabetes Market Size by Application (2016-2021) 9.3.2 Latin America Type 1 Diabetes Market Size by Application (2022-2027) 9.3.3 Latin America Type 1 Diabetes Market Size by Application (2016-2027) 9.4 Latin America Type 1 Diabetes Market Size by Country 9.4.1 Latin America Type 1 Diabetes Market Size by Country (2016-2021) 9.4.2 Latin America Type 1 Diabetes Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Type 1 Diabetes Market Size (2016-2027) 10.2 Middle East & Africa Type 1 Diabetes Market Size by Type 10.2.1 Middle East & Africa Type 1 Diabetes Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Type 1 Diabetes Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Type 1 Diabetes Market Size by Type (2016-2027) 10.3 Middle East & Africa Type 1 Diabetes Market Size by Application 10.3.1 Middle East & Africa Type 1 Diabetes Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Type 1 Diabetes Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Type 1 Diabetes Market Size by Application (2016-2027) 10.4 Middle East & Africa Type 1 Diabetes Market Size by Country 10.4.1 Middle East & Africa Type 1 Diabetes Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Type 1 Diabetes Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott 11.1.1 Abbott Company Details 11.1.2 Abbott Business Overview 11.1.3 Abbott Type 1 Diabetes Introduction 11.1.4 Abbott Revenue in Type 1 Diabetes Business (2016-2021) 11.1.5 Abbott Recent Development 11.2 Bayer 11.2.1 Bayer Company Details 11.2.2 Bayer Business Overview 11.2.3 Bayer Type 1 Diabetes Introduction 11.2.4 Bayer Revenue in Type 1 Diabetes Business (2016-2021) 11.2.5 Bayer Recent Development 11.3 Eli Lilly 11.3.1 Eli Lilly Company Details 11.3.2 Eli Lilly Business Overview 11.3.3 Eli Lilly Type 1 Diabetes Introduction 11.3.4 Eli Lilly Revenue in Type 1 Diabetes Business (2016-2021) 11.3.5 Eli Lilly Recent Development 11.4 BD 11.4.1 BD Company Details 11.4.2 BD Business Overview 11.4.3 BD Type 1 Diabetes Introduction 11.4.4 BD Revenue in Type 1 Diabetes Business (2016-2021) 11.4.5 BD Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Type 1 Diabetes Introduction 11.5.4 Johnson & Johnson Revenue in Type 1 Diabetes Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Merck 11.6.1 Merck Company Details 11.6.2 Merck Business Overview 11.6.3 Merck Type 1 Diabetes Introduction 11.6.4 Merck Revenue in Type 1 Diabetes Business (2016-2021) 11.6.5 Merck Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Type 1 Diabetes Introduction 11.7.4 Pfizer Revenue in Type 1 Diabetes Business (2016-2021) 11.7.5 Pfizer Recent Development 11.8 AstraZeneca 11.8.1 AstraZeneca Company Details 11.8.2 AstraZeneca Business Overview 11.8.3 AstraZeneca Type 1 Diabetes Introduction 11.8.4 AstraZeneca Revenue in Type 1 Diabetes Business (2016-2021) 11.8.5 AstraZeneca Recent Development 11.9 Roche 11.9.1 Roche Company Details 11.9.2 Roche Business Overview 11.9.3 Roche Type 1 Diabetes Introduction 11.9.4 Roche Revenue in Type 1 Diabetes Business (2016-2021) 11.9.5 Roche Recent Development 11.10 Smiths Medical 11.10.1 Smiths Medical Company Details 11.10.2 Smiths Medical Business Overview 11.10.3 Smiths Medical Type 1 Diabetes Introduction 11.10.4 Smiths Medical Revenue in Type 1 Diabetes Business (2016-2021) 11.10.5 Smiths Medical Recent Development 11.11 Medtronic 11.11.1 Medtronic Company Details 11.11.2 Medtronic Business Overview 11.11.3 Medtronic Type 1 Diabetes Introduction 11.11.4 Medtronic Revenue in Type 1 Diabetes Business (2016-2021) 11.11.5 Medtronic Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Type 1 Diabetes Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Rapid Acting Insulin Analogs Table 3. Key Players of Long Acting Insulin Analogs Table 4. Key Players of Premix Insulin Analogs Table 5. Global Type 1 Diabetes Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Type 1 Diabetes Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Type 1 Diabetes Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Type 1 Diabetes Market Share by Regions (2016-2021) Table 9. Global Type 1 Diabetes Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Type 1 Diabetes Market Share by Regions (2022-2027) Table 11. Type 1 Diabetes Market Trends Table 12. Type 1 Diabetes Market Drivers Table 13. Type 1 Diabetes Market Challenges Table 14. Type 1 Diabetes Market Restraints Table 15. Global Type 1 Diabetes Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Type 1 Diabetes Market Share by Players (2016-2021) Table 17. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 1 Diabetes as of 2020) Table 18. Ranking of Global Top Type 1 Diabetes Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Type 1 Diabetes Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Type 1 Diabetes Product Solution and Service Table 22. Date of Enter into Type 1 Diabetes Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million) Table 25. Global Type 1 Diabetes Revenue Market Share by Type (2016-2021) Table 26. Global Type 1 Diabetes Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Type 1 Diabetes Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Type 1 Diabetes Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Type 1 Diabetes Revenue Market Share by Application (2016-2021) Table 30. Global Type 1 Diabetes Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Type 1 Diabetes Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million) Table 33. North America Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million) Table 35. North America Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Type 1 Diabetes Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Type 1 Diabetes Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Type 1 Diabetes Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Type 1 Diabetes Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Type 1 Diabetes Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Type 1 Diabetes Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Type 1 Diabetes Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Type 1 Diabetes Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Type 1 Diabetes Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Type 1 Diabetes Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Type 1 Diabetes Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Type 1 Diabetes Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Type 1 Diabetes Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Type 1 Diabetes Market Size by Country (2022-2027) & (US$ Million) Table 62. Abbott Company Details Table 63. Abbott Business Overview Table 64. Abbott Type 1 Diabetes Product Table 65. Abbott Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 66. Abbott Recent Development Table 67. Bayer Company Details Table 68. Bayer Business Overview Table 69. Bayer Type 1 Diabetes Product Table 70. Bayer Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 71. Bayer Recent Development Table 72. Eli Lilly Company Details Table 73. Eli Lilly Business Overview Table 74. Eli Lilly Type 1 Diabetes Product Table 75. Eli Lilly Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 76. Eli Lilly Recent Development Table 77. BD Company Details Table 78. BD Business Overview Table 79. BD Type 1 Diabetes Product Table 80. BD Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 81. BD Recent Development Table 82. Johnson & Johnson Company Details Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson Type 1 Diabetes Product Table 85. Johnson & Johnson Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 86. Johnson & Johnson Recent Development Table 87. Merck Company Details Table 88. Merck Business Overview Table 89. Merck Type 1 Diabetes Product Table 90. Merck Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 91. Merck Recent Development Table 92. Pfizer Company Details Table 93. Pfizer Business Overview Table 94. Pfizer Type 1 Diabetes Product Table 95. Pfizer Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 96. Pfizer Recent Development Table 97. AstraZeneca Company Details Table 98. AstraZeneca Business Overview Table 99. AstraZeneca Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 100. AstraZeneca Recent Development Table 101. Roche Company Details Table 102. Roche Business Overview Table 103. Roche Type 1 Diabetes Product Table 104. Roche Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 105. Roche Recent Development Table 106. Smiths Medical Company Details Table 107. Smiths Medical Business Overview Table 108. Smiths Medical Type 1 Diabetes Product Table 109. Smiths Medical Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 110. Smiths Medical Recent Development Table 111. Medtronic Company Details Table 112. Medtronic Business Overview Table 113. Medtronic Type 1 Diabetes Product Table 114. Medtronic Revenue in Type 1 Diabetes Business (2016-2021) & (US$ Million) Table 115. Medtronic Recent Development Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global Type 1 Diabetes Market Share by Type: 2020 VS 2027 Figure 2. Rapid Acting Insulin Analogs Features Figure 3. Long Acting Insulin Analogs Features Figure 4. Premix Insulin Analogs Features Figure 5. Global Type 1 Diabetes Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Diagnostic clinics Case Studies Figure 8. Type 1 Diabetes Report Years Considered Figure 9. Global Type 1 Diabetes Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Type 1 Diabetes Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Type 1 Diabetes Market Share by Regions: 2020 VS 2027 Figure 12. Global Type 1 Diabetes Market Share by Regions (2022-2027) Figure 13. Global Type 1 Diabetes Market Share by Players in 2020 Figure 14. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 1 Diabetes as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Type 1 Diabetes Revenue in 2020 Figure 16. Global Type 1 Diabetes Revenue Market Share by Type (2016-2021) Figure 17. Global Type 1 Diabetes Revenue Market Share by Type (2022-2027) Figure 18. North America Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Type 1 Diabetes Market Share by Type (2016-2027) Figure 20. North America Type 1 Diabetes Market Share by Application (2016-2027) Figure 21. North America Type 1 Diabetes Market Share by Country (2016-2027) Figure 22. United States Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Type 1 Diabetes Market Share by Type (2016-2027) Figure 26. Europe Type 1 Diabetes Market Share by Application (2016-2027) Figure 27. Europe Type 1 Diabetes Market Share by Country (2016-2027) Figure 28. Germany Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Type 1 Diabetes Market Share by Type (2016-2027) Figure 36. Asia-Pacific Type 1 Diabetes Market Share by Application (2016-2027) Figure 37. Asia-Pacific Type 1 Diabetes Market Share by Region (2016-2027) Figure 38. China Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Type 1 Diabetes Market Share by Type (2016-2027) Figure 46. Latin America Type 1 Diabetes Market Share by Application (2016-2027) Figure 47. Latin America Type 1 Diabetes Market Share by Country (2016-2027) Figure 48. Mexico Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Type 1 Diabetes Market Share by Type (2016-2027) Figure 52. Middle East & Africa Type 1 Diabetes Market Share by Application (2016-2027) Figure 53. Middle East & Africa Type 1 Diabetes Market Share by Country (2016-2027) Figure 54. Turkey Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Type 1 Diabetes Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Abbott Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 58. Bayer Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 59. Eli Lilly Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 60. BD Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 61. Johnson & Johnson Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 62. Merck Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 63. Pfizer Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 64. AstraZeneca Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 65. Roche Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 66. Smiths Medical Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 67. Medtronic Revenue Growth Rate in Type 1 Diabetes Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Abbott Bayer Eli Lilly BD Johnson & Johnson Merck Pfizer AstraZeneca Roche Smiths Medical Medtronic